Home - Products - Angiogenesis - FGFR - Crocin I

Crocin I

CAS No. 94238-00-3

Crocin I( —— )

Catalog No. M19276 CAS No. 94238-00-3

Crocin I has anti atherosclerosis and hypolipidemic effects.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	37	In Stock
10MG	29	In Stock
25MG	41	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Crocin I
Note

Research use only, not for human use.
Brief Description

Crocin I has anti atherosclerosis and hypolipidemic effects.
Description

Crocin I has anti atherosclerosis and hypolipidemic effects.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

FGFR
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

94238-00-3
Formula Weight

976.97
Molecular Formula

C44H64O24
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 30 mg/mL
SMILES

CC(=CC=CC=C(C)C=CC=C(C)C(=O)OC1C(C(C(C(O1)COC2C(C(C(C(O2)CO)O)O)O)O)O)O)C=CC=C(C)C(=O)OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

FIIN-4

FIIN-4 is a covalent inhibitor of FGFR and can be used in studies about metastatic breast cancer.
BLU-554

BLU-554 (Fisogatinib, BLU554) is a novel potent, highly selective and orally bioavailable inhibitor of FGFR4 designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation.
Erdafitinib

Erdafitinib (JNJ-42756493) is a highly potent and selective, small-molecule inhibitor of FGFR family.

Sign In Join Free